MDCO - The Medicines Company (MDCO) CEO Mark Timney on Q3 2019 Results - Earnings Call Transcript
The Medicines Company (MDCO)
Q3 2019 Earnings Conference Call
October 30, 2019 8:30 AM ET
Company Participants
Krishna Gorti - Vice President of Investor Relations
Mark Timney - Chief Executive Officer
Christopher Visioli - Chief Financial Officer
Peter Wijngaard - Chief Development Officer
Christopher Visioli - Chief Development Officer, Peter Wijngaard
Conference Call Participants
Umer Raffat - Evercore
Dae Gon - SVB
Jessica Fye - JPMorgan
Tazeen Ahmad - Bank of America
Yasmeen Rahimi - Roth Capital
Paul Choi - Goldman Sachs
Chris Shibutani - Cowen
Mayank Mamtani - B. Riley
Akash Tewari - Wolfe